5Evanthia Diamanti-Kandarakis.Insulin resistance in PCOS[J]. Endocrine . 2006 (1)
6Monique Y. Boudreaux PhD,Evelyn O. Talbott DrPH, MPH,Kevin E. Kip PhD,Maria M. Brooks PhD,Selma F. Witchel MD.Risk of T2DM and impaired fasting glucose among pcos subjects: Results of an 8-year follow-up[J]. Current Diabetes Reports . 2006 (1)
7Carmina E,,Lobo R A.Use of fasting blood to assess the prev-alence of insulin resistance in women with polycystic ovarysyndrome. Fertility and Sterility . 2004
8Georgopoulos N A,Saltamavros A D,Vervita Vet al.Basalmetabolic rate is decreased in women with polycystic ovarysyndrome and biochemical hyperandrogenemia and is associat-ed with insulin resistance. Fertility and Sterility . 2009
9Lord J,Thomas R,Fox Bet al.The effect of metformin on fatdistribution and the metabolic syndrome in women with poly-cystic ovary syndrome-a randomized,double-blind,placebo-controlled trial. BJOG . 2006
10Cupisti S,Haberle L,Dittrich Ret al.Smoking is associatedwith increased free testosterone and fasting insulin levels inwomen with polycystic ovary syndrome,resulting in aggra-va-ted insulin resistance. Fertility and Sterility . 2010
3[1]Burghen GA, Givens JR, Kitabchi AE. Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease. J Clin Endocrinol Metab ,1980,50: 113
4[2]Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev, 1997, 18: 774
5[3]Dunaif A, Thomas A. Current concepts in the polycystic ovary syndrome. Annu Rev Med, 2001, 52: 401
6[4]Ovalle F, Azziz R. Insulin resistence, polycystic ovary syndrome, and type 2 diabetes mellitus. Fertil Steril, 2002, 77: 1095
7[5]American Diabetes Association. Consensus development conference on insulin resistance. Diabetes Care, 1998, 21: 310
8[6]World Health Organization (WHO). Definition, diagnosis and classification of diabetes mellitus and its complication-report of a WHO consultation, part 1: diagnosis and classification of diabetes mellitus. Geneva, Switzerland: WHO, 1999
9Dunaif A,Scott D,Finegood D,et al.The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome[J].Clin Endocrinol Metab,1996,81 (9):3299 -3306.
10Essah PA,Aorudonidze T,Iuomo MJ,et al.Effects of short-term and long-term meformin treatment on menstrual cyclicity in women with polyeystic ovary syndrome[J].Fertil Stefil,2006,86(1):230-232.
